Myeloid immune cells play key roles in aortic health and disease

The aorta is often viewed primarily as the body's largest blood vessel-a durable conduit that delivers oxygen-rich blood from the heart to every organ. But growing evidence suggests that the aortic wall is also an active immune environment. Immune cells residing within, or recruited to, different parts of the aorta may influence how this vessel develops, adapts to mechanical stress and becomes vulnerable to disease.

A new review published in Myeloid Cells brings together current evidence on the role of myeloid leukocytes in the aorta. Myeloid leukocytes are cells of the innate immune system, including monocytes, macrophages, dendritic cells and neutrophils. These cells are widely known for helping the body respond to infection and injury, but they also participate in tissue repair, inflammation and long-term remodeling of blood vessels.

The review, "Myeloid leukocytes in the aorta: Roles in development and disease," examines how these immune cells shape the aortic environment from prenatal development through adulthood, and how their functions may change in major aortic disorders. The authors synthesize findings from experimental models, human tissue studies and emerging clinical research.

The aorta is not immunologically uniform

A central message of the review is that the aorta should not be treated as one biologically uniform structure. Its regions-including the aortic root, arch, thoracic aorta and abdominal aorta-differ in embryonic origin, blood-flow patterns, mechanical forces and vessel-wall composition.

These differences may help explain why diseases such as aortic aneurysm, aortic dissection and calcific aortic valve stenosis arise in particular anatomical locations and progress differently among patients.

Myeloid immune cells also vary across these regions. Some are tissue-resident cells that help maintain local balance under normal conditions. Others are recruited from the bloodstream in response to injury, inflammation or altered blood flow. Depending on the disease setting and stage, these cells may help resolve damage or may contribute to persistent inflammation and destructive tissue remodeling.

From normal maintenance to vascular disease

Under healthy conditions, macrophages and other myeloid cells can support tissue surveillance, remove damaged material and contribute to repair. However, the same immune processes can become dysregulated when inflammation persists.

The review discusses myeloid-cell involvement across several important aortic conditions:

1. Congenital aortic disease: Immune-cell activity during development may interact with genetic and structural factors that shape the aorta before birth.
2. Calcific aortic valve stenosis: Inflammatory cells may contribute to the progression from early valve injury to fibrosis and calcification, which can eventually restrict blood flow from the heart.
3. Aortic aneurysm: Persistent inflammation, immune-cell recruitment and enzyme release may weaken the vessel wall and contribute to its enlargement.
4. Aortic dissection: Inflammation and impaired vessel-wall integrity may be linked to the acute tearing of layers within the aorta.

Although these conditions share some inflammatory features, the review emphasizes that they are not interchangeable. A mechanism identified in one part of the aorta, or in one disease, should not automatically be assumed to have the same role elsewhere.

A closer look at inflammation pathways

The article highlights several biological pathways that may be important in aortic disease. These include inflammatory signaling networks involving the NLRP3 inflammasome and cytokines such as interleukin-1 beta. Such pathways can amplify immune responses and may influence vessel-wall inflammation, cell death and tissue remodeling.

The review also considers how macrophage diversity may affect disease. Macrophages are often described as a single cell type, but in reality they can adopt distinct functional states depending on their local environment. Some may support repair; others may promote inflammation, fibrosis or breakdown of the extracellular matrix that gives the aortic wall its strength.

This growing recognition of immune-cell diversity could help researchers move beyond broad descriptions of "inflammation" and toward a more precise understanding of which cells, signals and disease stages may be most relevant for intervention.

Aging and clonal hematopoiesis may add another layer of risk

The review further discusses clonal hematopoiesis, an age-associated process in which blood-forming cells acquire mutations and expand over time. This phenomenon has been associated with elevated cardiovascular risk and may influence inflammatory activity in the vascular system.

Its potential relationship with aortic disease remains an active area of investigation. The authors identify it as an important example of how changes in the blood and immune system could interact with structural disease of the vessel wall, especially in older adults.

Implications for future diagnosis and treatment research

By organizing evidence across development, homeostasis and disease, the review outlines several directions for future research. These include the search for immune-related biomarkers that could help identify disease activity, improve risk stratification or monitor treatment response.

It also discusses potential therapeutic concepts, such as targeting selected inflammatory pathways or modifying harmful macrophage activity. However, the article makes clear that many of these approaches remain at the experimental or early translational stage. Much of the available evidence comes from laboratory studies, animal models or analyses of human tissue, and prospective clinical studies will be needed to determine which immune-targeted strategies are safe and effective for patients.

Rather than suggesting a single treatment solution, the review argues for a more targeted framework: future therapies may need to consider the location of disease within the aorta, its stage of progression and the specific immune-cell populations involved.

Why this matters

Aortic diseases can remain silent for years before causing serious complications. Better understanding of the immune processes that influence vessel-wall health may ultimately support earlier detection and more personalized prevention or treatment strategies.

The review provides a structured overview for researchers working at the intersection of cardiology, vascular biology and immunology. It also highlights an emerging shift in the field: the aorta is not only a mechanical structure exposed to blood pressure and flow, but also a dynamic tissue in which immune cells may influence health and disease over a lifetime.